Karen C McCowen1, Bruce R Bistrian. 1. Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
Abstract
PURPOSE OF REVIEW: This review will address recent research in metabolism of essential fatty acids and their long chain derivatives. Our main focus will be the association between essential fatty acid status and various disease states, as well as the effects of supplementation with essential fatty acids or their derivatives on a number of clinical outcomes. RECENT FINDINGS: There have been several papers over the last few years that show links between supplementation with fish oil (n-3 polyunsaturated fatty acids) and cardiovascular disease. Recent data suggest that the use of fish oil (containing n-3 fatty acids) in a variety of disorders such as cystic fibrosis, coronary disease and in the prevention of sudden death is beneficial. Several papers show reductions in systemic markers of inflammation. More widespread use of essential fatty acid derivatives in infant formula can certainly be questioned on the basis of the recent data. Fewer benefits are seen with ingestion of the essential fatty acids themselves, likely related to limited conversion to their long chain derivatives in humans. SUMMARY: Derivatives of essential fatty acids have the potential to modify a number of disease states, either ingested in greater quantities in the diet, or taken as supplements in the form of fish oil.
PURPOSE OF REVIEW: This review will address recent research in metabolism of essential fatty acids and their long chain derivatives. Our main focus will be the association between essential fatty acid status and various disease states, as well as the effects of supplementation with essential fatty acids or their derivatives on a number of clinical outcomes. RECENT FINDINGS: There have been several papers over the last few years that show links between supplementation with fish oil (n-3 polyunsaturated fatty acids) and cardiovascular disease. Recent data suggest that the use of fish oil (containing n-3 fatty acids) in a variety of disorders such as cystic fibrosis, coronary disease and in the prevention of sudden death is beneficial. Several papers show reductions in systemic markers of inflammation. More widespread use of essential fatty acid derivatives in infant formula can certainly be questioned on the basis of the recent data. Fewer benefits are seen with ingestion of the essential fatty acids themselves, likely related to limited conversion to their long chain derivatives in humans. SUMMARY: Derivatives of essential fatty acids have the potential to modify a number of disease states, either ingested in greater quantities in the diet, or taken as supplements in the form of fish oil.
Authors: Pei-Ra Ling; Charlotte E De Leon; Hau Le; Mark Puder; Bruce R Bistrian Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2010-08-02 Impact factor: 4.006
Authors: Karen C McCowen; Pei Ra Ling; Eric Decker; D Djordjevic; R F Roberts; J N Coupland; Bruce R Bistrian Journal: Nutr Clin Pract Date: 2010-12 Impact factor: 3.080
Authors: Margo N Woods; Christine A Wanke; Pei-Ra Ling; Kristy M Hendricks; Alice M Tang; Charlotte E Andersson; Kimberly R Dong; Heidi M B Sheehan; Bruce R Bistrian Journal: Am J Clin Nutr Date: 2009-02-25 Impact factor: 7.045
Authors: Neha Gadaria-Rathod; Peter G Dentone; Ellen Peskin; Maureen G Maguire; Ann Moser; Penny A Asbell Journal: J Ocul Pharmacol Ther Date: 2013-08-24 Impact factor: 2.671
Authors: Thomas Walther; Nils Dietrich; Martina Langhammer; Marzena Kucia; Harald Hammon; Ulla Renne; Wolf-Eberhard Siems; Cornelia C Metges Journal: PLoS One Date: 2011-03-09 Impact factor: 3.240